Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McMaster University

$120,000.00

Specific Strains of Bifidobacterium longum Cooperate to Improve Liver Health During Obesity

EF 2025-26

Résumé
Obesity affects nearly one-third of Canadians and is the strongest risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD begins with fat accumulation in the liver and can progress to more serious conditions like cirrhosis and liver cancer. Despite its rising prevalence, there are no approved treatments for MASLD. The gut and liver are closely connected. During obesity, the gut barrier weakens, allowing microbial products and dietary factors to enter the liver and worsen disease. Probiotics (live bacteria that improve health) are a promising strategy to target the community of microorganisms residing in the gut. However, it has been difficult to identify specific bacteria that provide meaningful benefits. In our lab, we screened hundreds of gut bacteria and discovered a cluster of Bifidobacterium longum strains that improved metabolism in C. elegans (nematode worms). We showed that an eight-strain mixture of B. longum improves blood sugar control and lowers body fat in obese mice. More recently, we identified two pairs of strains that reduced liver fat, inflammation, and fibrosis (scarring) during obesity. My project will test whether these benefits arise from individual strains or from synergy between strains. I will also investigate how these bacteria interact with liver cells and immune pathways to improve liver health. This research will inform the development of next-generation probiotics that are safe, targeted, and effective for Canadians living with obesity and MASLD.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
559317
Name
Conn Meghan O
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Specific Strains of Bifidobacterium longum Cooperate to Improve Liver Health During Obesity
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Bacteria; Fibrosis; Inflammation; Liver; Mash; Masld; Obesity; Probiotics; Steatosis
Abstract
Obesity affects nearly one-third of Canadians and is the strongest risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD begins with fat accumulation in the liver and can progress to more serious conditions like cirrhosis and liver cancer. Despite its rising prevalence, there are no approved treatments for MASLD. The gut and liver are closely connected. During obesity, the gut barrier weakens, allowing microbial products and dietary factors to enter the liver and worsen disease. Probiotics (live bacteria that improve health) are a promising strategy to target the community of microorganisms residing in the gut. However, it has been difficult to identify specific bacteria that provide meaningful benefits. In our lab, we screened hundreds of gut bacteria and discovered a cluster of Bifidobacterium longum strains that improved metabolism in C. elegans (nematode worms). We showed that an eight-strain mixture of B. longum improves blood sugar control and lowers body fat in obese mice. More recently, we identified two pairs of strains that reduced liver fat, inflammation, and fibrosis (scarring) during obesity. My project will test whether these benefits arise from individual strains or from synergy between strains. I will also investigate how these bacteria interact with liver cells and immune pathways to improve liver health. This research will inform the development of next-generation probiotics that are safe, targeted, and effective for Canadians living with obesity and MASLD.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Conn, Meghan O
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~